<VariationArchive RecordType="classified" VariationID="635266" VariationName="NM_000110.4(DPYD):c.1898del (p.Pro633fs)" VariationType="Deletion" Accession="VCV000635266" Version="5" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2023-12-30" DateCreated="2017-12-26" MostRecentSubmission="2023-12-30">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="623099" VariationID="635266">
      <GeneList>
        <Gene Symbol="DPYD" FullName="dihydropyrimidine dehydrogenase" GeneID="1806" HGNC_ID="HGNC:3012" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1p21.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="97077743" stop="97921059" display_start="97077743" display_stop="97921059" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="97543298" stop="98386614" display_start="97543298" display_stop="98386614" Strand="-" />
          </Location>
          <OMIM>612779</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000110.4(DPYD):c.1898del (p.Pro633fs)</Name>
      <CanonicalSPDI>NC_000001.11:97450065:GG:G</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1p21.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="97450066" stop="97450066" display_start="97450066" display_stop="97450066" variantLength="1" positionVCF="97450065" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="97915622" stop="97915622" display_start="97915622" display_stop="97915622" variantLength="1" positionVCF="97915621" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>P633fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.97915623del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.97915623del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.97450067del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.97450067del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008807.2" sequenceAccession="NG_008807" sequenceVersion="2" change="g.475994del">
            <Expression>NG_008807.2:g.475994del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000110.4" sequenceAccession="NM_000110" sequenceVersion="4" change="c.1898del" MANESelect="true">
            <Expression>NM_000110.4:c.1898del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000101.2" sequenceAccession="NP_000101" sequenceVersion="2" change="p.Pro633fs">
            <Expression>NP_000101.2:p.Pro633fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_722" sequenceAccession="LRG_722">
            <Expression>LRG_722:g.475994del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="612779.0005" DB="OMIM" />
        <XRef Type="rs" ID="72549303" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000110.4(DPYD):c.1898del (p.Pro633fs) AND fluorouracil response - Other" Accession="RCV000786628" Version="3">
        <ClassifiedConditionList TraitSetID="47947">
          <ClassifiedCondition>fluorouracil response - Other</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>reviewed by expert panel</ReviewStatus>
            <Description DateLastEvaluated="2021-03-24" SubmissionCount="1">drug response</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000110.4(DPYD):c.1898del (p.Pro633fs) AND Dihydropyrimidine dehydrogenase deficiency" Accession="RCV002267740" Version="2">
        <ClassifiedConditionList TraitSetID="121">
          <ClassifiedCondition DB="MedGen" ID="C1959620">Dihydropyrimidine dehydrogenase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-06-11" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-03-24" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2017-12-26" MostRecentSubmission="2023-12-30">
        <ReviewStatus>reviewed by expert panel</ReviewStatus>
        <Description>drug response</Description>
        <Citation Type="general">
          <ID Source="PubMed">10071185</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24648345</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9254861</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9439663</ID>
        </Citation>
        <Citation Type="general">
          <URL>https://www.pharmgkb.org/clinicalAnnotation/1447989671</URL>
        </Citation>
        <Citation Type="general">
          <URL>https://www.pharmgkb.org/variant/PA166153897</URL>
        </Citation>
        <DescriptionHistory Dated="2022-07-26">
          <Description>drug response</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-07-26">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="121" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="1107" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hereditary Thymine-Uraciluria</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Dihydropyrimidine dehydrogenase deficiency</ElementValue>
                <XRef ID="Dihydropyrimidine+Dehydrogenase+Deficiency/2282" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010130" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">DPD deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pyrimidinemia familial</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">DPYD DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="274270" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DPYDD</ElementValue>
                <XRef Type="MIM" ID="274270" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="19" />
                <XRef ID="19" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="DailyMed Drug Label, 2020">
                <URL>https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c45f5286-a52b-43e5-8a6f-d0312e7da0c8</URL>
                <CitationText>DailyMed Drug Label, FLUOROURACIL, 2020</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="CPIC, 2017">
                <ID Source="PubMed">29152729</ID>
                <ID Source="pmc">5760397</ID>
              </Citation>
              <XRef ID="1675" DB="Orphanet" />
              <XRef ID="C1959620" DB="MedGen" />
              <XRef ID="MONDO:0010130" DB="MONDO" />
              <XRef Type="MIM" ID="274270" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="47947" Type="DrugResponse" ContributesToAggregateClassification="true">
            <Trait ID="42163" Type="DrugResponse">
              <Name>
                <ElementValue Type="Preferred">fluorouracil response - Other</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="20614" SubmissionDate="2017-12-22" DateLastUpdated="2017-12-26" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="612779.0005_DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY" title="DPYD, 1-BP DEL, 1897C_DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY" />
        <ClinVarAccession Accession="SCV000020614" DateUpdated="2017-12-26" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1997-08-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a child with DPD deficiency (274270), born of consanguineous parents, Vreken et al. (1997) identified a homozygous 1-bp deletion (1897delC) in the DPYD gene, resulting in a frameshift and premature termination. At the age of 9 months the patient showed febrile convulsions, severe neuromotor retardation, and spastic tetraplegia. Cerebral MRI showed ventriculomegaly with white matter hypodensity. At the age of 6 years, thymine-uraciluria was noted and DPD deficiency was demonstrated in fibroblasts. An earlier-born child had died before her first birthday with severe neuromotor retardation and febrile convulsions. Surprisingly, the father of the patient was also completely DPD deficient, although he had no history of convulsions. The mother of the patient showed intermediate DPD activity consistent with obligate carrier status. The patient was heterozygous for this 1-bp deletion, whereas the father was thought to be homozygous. The nature of the heterozygous mutation carried by the mother and transmitted to the son was not determined.</Attribute>
              <Citation>
                <ID Source="PubMed">9254861</ID>
              </Citation>
              <XRef DB="OMIM" ID="274270" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DPYD" />
          </GeneList>
          <Name>DPYD, 1-BP DEL, 1897C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 1897C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="612779.0005" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1809154" SubmissionDate="2021-11-18" DateLastUpdated="2021-12-12" DateCreated="2019-06-30">
        <ClinVarSubmissionID localKey="1450416496|fluorouracil response - Other" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV000925450" DateUpdated="2021-12-12" DateCreated="2019-06-30" Type="SCV" Version="2" SubmitterName="PharmGKB" OrgID="500295" OrganizationCategory="resource" OrgAbbreviation="PharmGKB" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-03-24">
          <ReviewStatus>reviewed by expert panel</ReviewStatus>
          <GermlineClassification>drug response</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10071185</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24648345</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9439663</ID>
          </Citation>
          <Citation>
            <URL>https://www.pharmgkb.org/clinicalAnnotation/1447989671</URL>
          </Citation>
          <Comment>PharmGKB Level of Evidence 1A: Level 1A clinical annotations describe variant-drug combinations that have variant-specific prescribing guidance available in a current clinical guideline annotation or an FDA-approved drug label annotation. Annotations of drug labels or clinical guidelines must give prescribing guidance for specific variants (e.g. CYP2C9*3, HLA-B*57:01) or provide mapping from defined allele functions to diplotypes and phenotypes to be used as supporting evidence for a level 1A clinical annotation. Level 1A clinical annotations must also be supported by at least one publication in addition to a clinical guideline or drug label with variant-specific prescribing guidance.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Pharmacogenomics knowledge for personalized medicine</Attribute>
          <Citation>
            <ID Source="PubMed">22992668</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DPYD" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <XRefList>
            <XRef DB="dbSNP" ID="72549303" Type="rsNumber" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.11:g.97450067del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="DrugResponse">
          <Trait Type="DrugResponse">
            <Name>
              <ElementValue Type="Preferred">fluorouracil response - Other</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>https://www.pharmgkb.org/variant/PA166153897</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>PharmGKB-ClinVar 2019-06</SubmissionName>
          <SubmissionName>PharmGKB-SNP 2021-11</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7841000" SubmissionDate="2023-12-07" DateLastUpdated="2023-12-30" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000110.4:c.1898del|OMIM:274270" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004194109" DateUpdated="2023-12-30" DateCreated="2023-12-30" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000110.4:c.1898del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="274270" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="20614" TraitType="Disease" MappingType="Name" MappingValue="DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY" MappingRef="Preferred">
        <MedGen CUI="C1959620" Name="Dihydropyrimidine dehydrogenase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1809154" TraitType="DrugResponse" MappingType="Name" MappingValue="fluorouracil response - Other" MappingRef="Preferred">
        <MedGen CUI="None" Name="fluorouracil response - Other" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7841000" TraitType="Disease" MappingType="XRef" MappingValue="274270" MappingRef="OMIM">
        <MedGen CUI="C1959620" Name="Dihydropyrimidine dehydrogenase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

